2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

AMD3100 (Plerixafor) as a Single-Dose Stem Cell Mobilizing Agent in Vascularized Composite Tissue Allograft (VCA) Transplantation in a Canine Model

B. Swearingen,^1,2 S. Graves,^2,3 R. Storb,^2,3 D. Mathes.^1,2
Amiodarone Use Increases Morbidity Not Mortality in Pediatric Heart Transplant Recipients

S. Amdani, A. Dalal, K. Simpson, J. Scheel, A. Abarbanell, P. Eghtesady, C. Canter, C. Castleberry.
An Early Look at the OPTN's New SLK Allocation Policy

A. Kucheryavaya,¹ R. Formica,² N. Turgeon,³ D. Stewart,¹ A. Wilk.¹
An Economic Analysis of the UK Pancreas Allocation Scheme

K. Burke,¹ S. Birch,^2,3 T. Augustine.¹
An Effective Tolerance Approach for Porcine Islet Xenotransplantation in Humanized Mice

F. Lee,¹ A. Dangi,¹ M. Burnette,¹ X. Zhang,¹ B. Hering,² X. Luo.¹
An Enhanced Educational Program for Kidney Transplant Candidates and Their Supports: Knowledge Gained but Room for Improvement

E. Clifton, A. Eshelman, D. Kim, A. Patel, P. Williams, D. Nicholson, K. Hogan, E. Rubinstein, D. Ramirez, N. Sadik, M. Jesse.
An In Vitro Model of Human Antibody-Mediated Rejection Depicts Key Role for NK Cells

L. Hidalgo,¹ M. Racape,² A. Loupy,² C. Lefaucheur.²
An Increase in Spot Urine Protein Excretion during the First Year after Kidney Transplantation Associates with Subclinical De-Novo Donor-Specific Antibodies and Microvascular Inflammation at 1-Year Surveillance Biopsies

M. Arnol,¹ G. Mlin[scaron]ek,¹ M. Oblak,¹ A. Kandus,¹ N. Kojc,² J. Buturović-Ponikvar.¹
An Individualized Strategy Using Virus and Immune-Based Markers to Prevent Cytomegalovirus Disease after Face Transplantation

R. Razonable, H. Amer, S. Mardini.
An Initial Experience with the Endowrist Robotic Endostapling Device for Renal Donor Nephrectomy

M. Tan, H. Pollinger.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z